US · Healthcare

LakeShore Biopharma Co., Ltd (LSBCF)

Biotechnology

LakeShore Biopharma Co., Ltd (LSBCF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for LSBCF

P/E ratio

25.00

LakeShore Biopharma Co., Ltd (LSBCF) — FAQ

What is LSBCF's P/E ratio?

The price-to-earnings (P/E) ratio for LakeShore Biopharma Co., Ltd (LSBCF) is 25.00 (data as of 2026-05-23).

Does LakeShore Biopharma Co., Ltd pay a dividend?

Dividend yield is not available in the current snapshot for LakeShore Biopharma Co., Ltd (LSBCF). Check the MyAverix Finance app for the latest dividend data.

What sector is LakeShore Biopharma Co., Ltd in?

LakeShore Biopharma Co., Ltd (LSBCF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is LSBCF listed on?

LSBCF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)